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Abstract: Breast cancer is caused by uncontrolled growth of breast cells. It is more common in women as compared to 
that in men. The breast cancer may be interlinked with the drinking of alcohol, smoking, sex, hormonal therapy, obesity, 
family history and age. Various epidemiologic studies suggest the role of metals e.g., nickel (Ni), zinc (Zn), arsenic (As), 
selenium (Se)and cadmium (Cd)as potential risk factors in breast cancer. Humans are exposed to these metals by means 
of drinking water, food and air. The oxidative theory suspects that the complexes formed from these metals in vivo, near 
the location of DNA, catalyze the redox reactions which results in oxidation of DNA. The metals like arsenic (As), 
chromium (Cr), aluminum (Al), cadmium (Cd) and chromium (Cr)which exist in trace amount are considered as 
carcinogens for organisms by IARC (International Agency for Research on Cancer). The carcinogenicity of these metals 
mainly depends upon their chemical structure and oxidation states. 
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Introduction 
Breast cancer is a common women disease that appears 
in the breast tissues. Its initial symptoms include the 
protuberances in the breast, shape change of breast, fatty 
skin, fluid releasing from nipples and red scaly spots of 
skin (Apantaku, 2000). The in-situ breast cancer is 
mainly classified into lobular carcinoma in situ (LCIS) 
and ductal carcinoma in situ (DCIS) (Giuliano et al., 
2017).In USA, breast cancer is the cause of about 
48,000 deaths every year, with the report of 
approximate180,000 new cases annually (Apantaku, 
2000). Breast cancer is the most common primary 
malignancy and the second most common cause of 
cancer-related mortality among women in the United 
States (Afifi et al., 2020). Breast cancer is the leading 
cause of death and the most commonly diagnosed 
cancer among females. In 2018, about 2.1 million new 
cases were reported over the world. The highest 
incidence rate of breast cancer in women has been 
reported in Belgium, followed by Luxembourg and then 
Netherlands(Bray et al., 2018). Breast cancer is mostly 
linked to age; about 7% cases of breast cancer have been 
reported in women before the age of 40 yearsat global 
level (Anders et al., 2009). The breast cancer developing 
risks are: lack of physical exercise, female sex, drinking 
of alcohol, hormone replacement therapy, obesity, 
family history and age(Mustafa et al., 2016). 
Materials and Methods 
The current studies were carried out to review the 
literature relevant to the symptoms (Palesh et al., 2010) 
and risk factors (Angahar, 2017; Lakshmi et al., 2012) 
of breast cancer. The role of physical activity 
(Friedenreich, 2010), age (Bucholc et al., 2001), family 
history (Bakhshi et al., 2018; Lakshmi et al., 2012), race 
(Knaus, 2012), diet (Bandera et al., 2015)(Naseer et al., 
2018; Naseer et al., 2019; Rehman et al., 2018; Tahir et 
al., 2018; Vainio et al., 2002), genetic factor (Antoniou  
and Easton, 2006; Martin  and Weber, 2000), alcohol 
(Dumitrescu  and Shields, 2005; Essex et al., 2014), 
smoking (Jee et al., 1999; Reynolds et al., 2004), obesity 
(Byrne et al., 1991; Schapira et al., 1990), estrogen 
Level (Byrne et al., 2013; Yarden et al., 2002), 
radiations (Land et al., 2003; Mattsson et al., 1993; 
Preston et al., 2002) and heavy metals (cadmium, 
chromium, arsenic, lead, nickel, aluminum and zinc) in 
breast cancer are also reviewed (Alatise  andSchrauzer, 
2010; Aquino et al., 2012; Cantor et al., 1995; Choe et 
al., 2003; Chunhabundit,  2016; Cui et al., 2007; Darbre, 
2016; Farasani  and Darbre, 2015; Florea  and Büssel 
berg, 2011; Franklin  and Costello, 2009; Gallagher et 
al., 2010; Health  and Services, 1999; Johnson et al., 
2003; Kilic et al., 2004; Liu et al., 2010; Mandriota et 
al., 2016; McElroy et al., 2006; Romaniuk et al., 2015; 
Ruiz-Ramos et al., 2009; Saleh et al., 2011; Schrauzer, 
2008; Siewit et al., 2010; Sukumar et al., 1983; Sun et 
al., 2007; Ullah et al., 2019; Ying et al., 2009; 
Zhitkovich, 2011).  
Results and Discussion 
Factors Affecting the Rate of Breast Cancer 
The breast cancer is comprised of approximately 22.9% 
of all cancers (excluding non-melanoma skin cancers) 
and second most common cause of cancer deaths in 
women worldwide. The mortality rate due to breast 
cancer is higher in developing countries although the 
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developed nations have higher incidence rates 
(Angahar, 2017; Francies et al., 2020). Breast cancer 
involves either preventable or non-preventable risk 
factors. The non-preventable (beyond control) risk 
factors include medical history, family history and age. 
The preventable risk factors include the alcohol 
consumption, physical activity and weight (Lakshmi et 
al., 2012). 
Physical Activity and Family History 
Approximately 25% cancer risk is reduced in physically 
active women as compared to the least active women. 
Physical activity lowers the risk of breast cancer via 
multiple interrelated biologic pathways which may 
involve chronic inflammation, adipokines, insulin 
resistance, sex hormones and adiposity (Friedenreich, 
2010). 
Breast cancer occurrences and consequently death 
proportion rates usually increase with age. About 88% 
of breast cancers were reported in the women having 
age over 40 years. The risks of breast cancer 
development are maximum in women whose 
menstruation starts in early life or whose menopause 
period is late (Bucholc et al., 2001).  
About 5% of breast cancer cases are due to inherited 
family problems. If a female possesses one first degree-
female relative (daughter, mother, and sister) identified 
with breast cancer disease, then her breast cancer risk 
chance is doubled. If two such first relatives have been 
diagnosed, then the same risk of breast cancer is 
increased to five times. If breast cancer has been 
diagnosed in one’s father or brother, the risk is much 
higher(Lakshmi et al., 2012). 
Breast cancer in women is a very lethal factor that may 
cause the risks of physical, cerebral and social health. 
The treatment by chemotherapy which is an effective 
treatment method, disturbs the quality of life of patients 
and damages their brain, social and psychic well-being 
(Bakhshi et al., 2018). 
Race Diet and Genetic Factor 
Race is an intrinsic factor increasing the incidence of 
breast cancer. The breast cancer occurrence rate is 
higher in non-Hispanic white women than African and 
American females for many age groups (Knaus, 2012). 
Diet is considered as a risk factor of many different 
types of cancers including breast cancer. It is very 
important to control the sources of fats and red meat of 
animals because they contain the hormones and other 
growth factors (Bandera et al., 2015). To use of high fats 
increases breast cancer incidences. But fruits and 
vegetables reduce breast cancer incidences. The intake 
of vitamin D, calcium and phytoestrogens are also 
effective against breast cancer risks (Vainio et al., 
2002). The use of some vegetables and fruits has been 
found effective against cancer (Naseer et al., 2018; 
Naseer et al., 2019; Rehman et al., 2018). Some 
aflatoxins have also been known to cause cancer (Tahir 
et al., 2018).  
The genetic and environmental factors may also 
contribute to the development of breast cancer. Two 
breast cancer susceptible genes (BRCA1 and BRCA2) 
have been recognized. About 5% to 10% cases of breast 
cancer cases are reported due to changes in these genes. 
The variation in the number of gene classes is 
considered as the main reason of breast cancer disease 
(Martin  and Weber, 2000).The other main risk factor 
for breast cancer is family history, representing that 
genetic factors are important elements in the 
development of breast cancer. The susceptibility to 
breast cancer is intermediated through mutations in 
many genes (Antoniou  and Easton, 2006). 
Alcohol, Smoking and Obesity 
In most epidemiologic studies, it was found that 
drinking alcohol is associated with breast cancer. In 
such cases breast cancer is characterized by various 
mechanisms such as through mutagenesis by 
acetaldehyde, perturbation of estrogen metabolism and 
by inducing oxidative damage or by disturbing folate 
and carbon metabolism pathways containing single 
carbon. In human breast tissue, alcohol-metabolizing 
enzymes are present. From the metabolism of ethanol, 
reactive oxygen species are produced which may be 
involved in breast cancer. Genetic polymorphism is 
very important in enhancing a women breast cancer 
(Dumitrescu  andShields, 2005).  
It is clearly evident that all alcoholic beverages are the 
cause of different types of cancers. Alcohol may 
increase the risk of breast cancer, throat, mouth, and 
larynx, liver and bowel cancer in men. The risk of breast 
cancer is increased with alcohol drinking, the main 
mechanism through which breast cancer rate is 
increased by rising estrogen levels. Alcohol can affect 
the blood level of the estrogen hormone, which further 
increases the breast risk. Alcohol damages the DNA 
cells and in this way, breast cancer risk also increases. 
Women who take 3 alcoholic drinks in a week have a 
15% high risk of breast cancer. The risk of breast cancer 
is increased in women up to 10% for each extra 
alcoholic drink taken on regular basis(Essex et al., 
2014). 
It has been known that cigarette is a cause of cancer 
(Madigan et al., 1995). There is more chance of breast 
cancer developing in cigarette-smokers, verifying the 
function of cigarette in breast cancer (Reynolds et al., 
2004). More than 80 different cancer generating 
substances are present in tobacco smoke. When smoke 
passes through the lungs, it enters into the bloodstream 
and is drawn throughout the body (Jee et al., 1999). 
Obesity is also closely related to breast cancer. The 
incidences of breast cancer risk are increased by 18% 
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for every addition of 5 kg/m2 in body weight. The risk 
may also be increased due to high level of circulating 
estrogen (Byrne et al., 1991). It has been considered that 
the extra production of estrogen by obese females 
increases more effect on mammary epithelial cells. The 
non-protein part of estrogen available on the breast is 
responsible for the development of breast cancer. As the 
women attain weight in the upper part of the body 
including shoulders, nape of the neck, abdomen and in 
lower part of body such as on buttock and thigh then 
metabolic and hormonal irregularities are noted in 
obesity. The decreased level of sex hormone binding 
proteins and increased levels of non-protein bound-
estrogen in females having obesity can increase the risk 
of breast cancer (Schapira et al., 1990). 
Estrogen Level, BRCA1 and Radiation 
The age at menopause, reproductive history, 
breastfeeding, menarche and utilization of exogenous 
estrogen can increase the risk of breast cancer. In 
various cases, non-genetic breast cancer happens in 
menopausal women who keep more expression of the 
estrogen receptor. Estrogen has a minimum of two roles 
in breast cancer growth: (i) metabolism of estrogen may 
change or produce DNA- breaking free radicals and (ii) 
estrogen through its hormonal activity can proliferate 
cells in cancerous and precancerous lesions. 
Additionally, estrogen-receptor is an essential part of 
breast carcinoma, other mechanisms also take part in the 
generation of breast cancer. Mutation of BRCA1 
increases the incidences of breast cancer to 51% but 
about 85% by the period of 50 and 70 years. It also 
generates the ovarian cancer risk to 23% and 63% by the 
age of 50 and 70 years (Yarden et al., 2002) 
Metalloestrogens are small metalloids or metals ions 
acting as endocrine disruptors by stimulating the action 
of estrogens. Two classes of metal loestrogens have 
been identified: the first-class includes antimony, 
oxyanions, arsenite, selenite, vanadate and nitrite; 
second class is comprised of bivalent-cations like 
cadmium, copper, cobalt, nickel, calcium, mercury, tin, 
chromium and lead. In the lack of estradiol, the estrogen 
receptor is activated by Metalloestrogens; hence these 
metals can increase the risk of breast cancer 
development when there is direct exposure to them. 
Over the last 50-60 years, a significant increase of 
Metalloestrogens in the environment has occurred. 
Many metalloestrogens have a long biological half-life. 
The half-life of cadmium is between 10 to 30 years and 
it may retain in body and breast mammary tissues. 
Numerous studies explain that the exposure to cadmium 
(Cd) is the risk of breast cancer(Byrne et al., 2013). 
It is recognized that exposure of the breast to ionizing 
radiation elevates the relative risk of breast cancer, 
particularly in younger women (Mattsson et al., 1993). 
Women who are less than 20 years old are at high risk 
of radiation than those at older ages. The women who 
are more than 50 years old are not so much at risk of 
breast cancer (Preston et al., 2002). About 70,165 breast 
cancer cases were reported in women due to mixed 
gamma and neutrons radiation levels associated with 
Japanese atomic bomb (Land et al., 2003). 
Role of Heavy Metals in Breast Cancer 
Many epidemiologic studies suggest metals as potential 
risk factors of breast cancer. These metals include nickel 
(Ni), zinc (Zn), cadmium (Cd), selenium (Se) and 
arsenic (As), which naturally exist in the environment. 
These metals get exposure to the human beings by 
means of drinking water, food and air (Florea  and 
Büsselberg, 2006; Iqbal et al., 2019; Silvera  and Rohan, 
2007). Further studies confirmed that age-related breast 
cancer deaths in various countries are directly related 
with the dietary intake of Zn, Cd, Cr, Sn and As while 
they are inversely associated with dietary ingestion of 
Se due to anti-carcinogen properties of selenium 
(Schrauzer, 2009). Many studies have reported that 
breast cancer patients have irregular levels of Cd, Zn Se, 
and Cu (Saleh et al., 2011).  
Cadmium is a metallic element which exists in the 
environment due to weathering of cadmium bearing 
rocks and volcanic activity. It may also be released from 
various industrial products such as plastic stabilizers 
and coating processes, batteries, phosphate fertilizers 
and also from fuel vehicles combustion and tire 
outfit(Health  and Services, 1999). The in vivo and in 
vitro studies have shown that Cd can behave like a 
metalloestron (Cantor et al., 1995). Moreover, Cd also 
creates other estrogen-type effects, such as enhancing 
the uterine weight, modification of the uterine lining, 
increase of the epithelial density in mammary glands 
and also enhances the cell proliferation and aneuploidy 
(Johnson et al., 2003). 
It has been recognized by the US Environmental 
Protection Agency that main source of cadmium is food 
and tobacco burn (Siewit et al., 2010). Cadmium is a 
universal carcinogenic contaminant and possesses 
numerous biological effects leading to breast cancer 
(Gallagher et al., 2010 and (McElroy et al., 2006). There 
is significant risk of breast cancer by increased 
concentration of urinary cadmium (Siewit et al., 2010). 
Cadmium affects many cellular processes such as 
differentiation, proliferation and apoptosis (Siewit et al., 
2010). Cadmium also acts as an estrogen disruptor, that 
motivates the action of estrogen-receptor-α (ER-α) and 
increases the growth of mammary and uterine tissues 
(Schrauzer, 2008). Cadmium modifies gene expression 
and disturbs the transcription activity pattern altering 
intracellular signals (Sun et al., 2007). 
The DNA is also effected by Cr(VI), because it forms 
Cr-DNA adduct as a results of mutation and 
chromosomal breakage (Zhitkovich, 2011). Acute 
chromium toxicity will increase the incidence of 
different types of human cancers. It is observed that 
reduction of Cr(VI) to its lower oxidation states and its 
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free radical reactions are very carcinogenic (Kilic et al., 
2004). Multiple tissues such as intestine, esophagus, 
testes, stomach, prostrates and lungs are affected by 
chromium exposure (Chunhabundit, 2016). 
Arsenic (As) exposure is one of the strongest 
environmental carcinogen and is related to increased 
threats of different kinds of cancer (Ullah et al., 2019; 
Ying et al., 2009). The presence of As in drinking water 
increases the incidence of human cancer in lung, kidney, 
liver, bladder and skin (Ruiz-Ramos et al., 2009). Little 
concentration of As2O3 also creates carcinogenic 
effects after its  term exposure (Liu et al., 2010). Even 
though, arsenic trioxide is also part of traditional 
Chinese medicine (Liu et al., 2010). In clinical practice, 
it is used to cure hematologic malignancies (Florea  and 
Büsselberg, 2011). 
Breast cancer is associated with industrialization that 
contaminates the air, soil, and water by lead (Pb) and 
many more metals that cause risk factors for humans. 
Low concentration of Lead (0.5 ppm) in drinking water 
can increase the growth of mammary murine tumors in 
female C3Hmice infected by virus. It also promotes the 
tumor growth rate. High amount of lead is observed in 
blood and head hair samples of newly investigated 
breast cancer patients. The level of Pb in hair samples 
were directly linked to the sizes of tumors (Alatise  
andSchrauzer, 2010).  
Like Cd, nickel can also bind to ERα, generate cell 
proliferation and induce aneuploidy. However, many 
studies of cellular, animal and molecular level are 
needed to explain the exact mechanism of breast cancer 
pathogenesis through chronic nickel exposure. More 
structural research studies are needed to confirm the 
function of nickel as a metalloestrogens (Aquino et al., 
2012).  
Aluminum exposure is closely related to cause breast 
cancer. Mice were exposed to AlCl3resulting in 
malignant growth in mammary gland epithelial cells and 
the same effects were seen on the samples of human 
breast tissues (Darbre, 2016). Another research has also 
shown that exposure of Al to human breast cells has a 
tendency to produce uncontrolled growth (Mandriota et 
al., 2016). In an experimental study, it was observed that 
aluminum acts as a metal estrogen that behaves as an 
agonist for the estrogen receptor and shows a well-
known breast cancer risk (Mandriota et al., 2016). To 
minimize the exposure of aluminum to humans, it is 
necessary to use reverse osmosis filtration. This 
technique is very efficient to reduce the level of 
aluminum from copper mining waste (Farasani  and 
Darbre, 2015). 
Zinc is a component of various enzymes taking part in 
the chemical processes within the living cells including 
lactic, carbonic anhydrase, glutamic alkaline 
phosphatase and alcoholic dehydrogenase. This metal 
element also takes part in the activation of many 
enzymes. It is also liable for uncontrolled growth 
leading to cancer. Zinc accumulation also causes breast 
cancer. Zinc is essential for cell proliferation and it 
accumulates in mammary tumors and promotes tumor 
growth (Sukumar et al., 1983). Zinc, in minute quantity 
is very important for the normal functioning of cells. It 
acts as a cofactor for the structure and function of 
widespread range of cellular proteins such as enzymes, 
transcription factors and structural proteins. It regulates 
the immune system, gene expression, cell proliferation, 
growth and also controls apoptosis in malignant cells 
(Franklin  and Costello, 2009). 
Prevention of Cancer  
Epidemiological studies demonstrate that cancer can 
generally be prevented by more consumption of edible 
fruits and green leafy vegetables, avoiding from 
smoking and the effective control of infections. Other 
factors include the avoidance from intense sun 
exposure, increasing the physical activity and 
controlling the drinking of alcohol and to some extent 
red meat. An extensive reduction in the cases of breast 
cancer can possibly be achieved by modifications in the 
sex hormones level. Mechanistic studies of 
carcinogenesis reveal a significant role of endogenous 
oxidative damage to DNA which can be balanced by 
proper repair and defense mechanism. The cell division 
rate is most important factor as it governs the probability 
of altering DNA lesions to mutations and effects on 
growth, inflammation, cytotoxicity and hormones 
(Ames et al., 1995). 
Conclusion 
Breast cancer may be interlinked with the drinking of 
alcohol, smoking, sex, hormonal therapy, obesity, 
family history and age. Heavy metals and their metal 
compounds exhibit immense toxic effects on humans 
due to their carcinogenic properties. On one side, heavy 
metals cause pathogenesis of breast cancer, while on the 
other side they also prompt apoptosis and cytotoxicity 
in breast cancer cells. Therefore, awareness regarding 
carcinogenic mechanism of toxic metals is important. 
Industries releasing untreated wastewater into rivers, 
canals and streams containing different carcinogens 
heavy metals (Pb, Cd, Cr, Hg and As etc.) should install 
waste water treatment plants. Different ailments such as 
breast cancer, sexual, cerebral and neural diseases are 
likely to be caused by these toxic heavy metals. 
Educational programs are needed to promote the 
awareness of risks related to the exposure of toxic heavy 
metals in most affected areas.  
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